HomeTVRD • NASDAQ
add
Tvardi Therapeutics Inc
Previous close
$4.00
Day range
$3.92 - $4.05
Year range
$3.75 - $43.65
Market cap
37.71M USD
Avg Volume
120.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.94M | 4.62% |
Net income | -5.53M | -0.25% |
Net profit margin | — | — |
Earnings per share | -0.59 | — |
EBITDA | -5.91M | -4.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.46M | 286.31% |
Total assets | 39.02M | 211.82% |
Total liabilities | 11.16M | 102.30% |
Total equity | 27.87M | — |
Shares outstanding | 9.38M | — |
Price to book | 1.35 | — |
Return on assets | -35.87% | — |
Return on capital | -48.45% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.53M | -0.25% |
Cash from operations | -4.26M | 36.03% |
Cash from investing | 5.35M | — |
Cash from financing | -322.00K | -2,200.00% |
Net change in cash | 770.00K | 111.55% |
Free cash flow | -2.84M | — |
About
Founded
2017
Headquarters
Website
Employees
12
